U.S. regulators cleared the first generic competitor to Mylan'sEpiPen, after a yearslong delay that many said contributed to the emergency allergy drug's rapid rise in price.
Trending:
FDA approves Teva's generic EpiPen after yearslong delay
U.S. regulators cleared the first generic competitor to Mylan'sEpiPen, after a yearslong delay that many said contributed to the emergency allergy drug's rapid rise in price.